| Abstrakt: |
A recent report from Mayo Clinic Florida highlights the findings of a study on obesity, fitness, and wellness. The study focuses on the management of overactive bladder (OAB) and suggests that tibial nerve stimulation (TNS) could be a viable second-line therapy option, ahead of anticholinergic medication. The researchers argue that TNS should be considered due to its efficacy, side-effects profile, and cost-effectiveness. This commentary calls for an update to the current management guidelines for OAB. [Extracted from the article] |
